Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP) Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Timing of antibiotic administration and outcomes for patients with community-acquired pneumonia (CAP). NAC-CV Study Source: Eur Respir J 2006; 28: Suppl. 50, 349s Year: 2006
Clinical and laboratory predictors of survival in patients with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014
Effectiveness of immune stimulatory therapy in patient with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014
Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013
Biomarkers and severity in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012
Immunoglobulin levels and severity of community-acquired pneumonia (CAP) Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014
Does previous warfarin treatment effect complications and outcome in hospitalised patients with community-acquired pneumonia? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Modification of empirical antibiotic therapy in community acquired pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Physical deterioration during hospitalization in patients with community-acquired pneumonia Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions Year: 2015
Biomarkers in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012
Empirical treatment of community-acquired pneumonia after outpatient beta-lactam therapy Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015
PICTURE: Clinical pattern and pneumococcal infections in patients with community-acquired pneumonia (CAP) admitted to emergency department Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2010; 36: 128-134 Year: 2010
The neutrophil/lymphocyte ratio in predicting outcome for hospitalized patients with community-acquired pneumonia Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014
Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015
Clinical judgement on top of CURB65-score in predicting 30 days clinical outcome in patients with community acquired pneumonia (CAP) admitted to the hospital Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014
The outcome of community-acquired pneumonia in patients with COPD, asthma and ILD - a case-control study Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014
Comparative evaluation of timing of antibiotic intravenous-to-oral switch in pneumonia Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014